Eat the eggs before the toast
Semaglutide, marketed as Wegovy or Ozempic, has been shown to be a highly effective medications in regulating blood sugar and achieving weight loss, according to a recent study in JAMA Internal Medicine
* This study was commissioned by Felix Health and conducted by Angus Reid
Available clinical trial and pharmacovigilance data remain insufficient to establish whether semaglutide increases the risk of birth defects, miscarriage or other adverse outcomes, meaning treatment decisions should be made on a case-by-case basis with a licensed healthcare professional
For example, Mounjaro, a weight loss injection pen containing tirzepatide, is similar to Ozempic
Certificates of Analysis for all BIOVEA branded products are available upon request